These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 30465076)

  • 1. Novel positioning from obesity to cancer: FTO, an m
    Chen J; Du B
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
    Azzam SK; Alsafar H; Sajini AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation.
    Zhou S; Bai ZL; Xia D; Zhao ZJ; Zhao R; Wang YY; Zhe H
    Mol Carcinog; 2018 May; 57(5):590-597. PubMed ID: 29315835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression.
    Zheng QK; Ma C; Ullah I; Hu K; Ma RJ; Zhang N; Sun ZG
    Onco Targets Ther; 2021; 14():4837-4846. PubMed ID: 34556998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
    Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
    Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12.
    Chen Z; Zhong X; Xia M; Liu C; Tang W; Liu G; Yi Y; Guo Y; Jiang Q; Zu X; Zhong J
    Cell Death Dis; 2024 Oct; 15(10):733. PubMed ID: 39379360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
    Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.
    Annapoorna PK; Iyer H; Parnaik T; Narasimhan H; Bhattacharya A; Kumar A
    Neuroscience; 2019 Oct; 418():15-24. PubMed ID: 31442565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing.
    Bartosovic M; Molares HC; Gregorova P; Hrossova D; Kudla G; Vanacova S
    Nucleic Acids Res; 2017 Nov; 45(19):11356-11370. PubMed ID: 28977517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
    Xie D; Yang K; Xu Y; Li Y; Liu C; Dong Y; Chi J; Yin X
    J Diabetes Complications; 2024 Aug; 38(8):108801. PubMed ID: 38935979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy.
    Xiang M; Liu W; Tian W; You A; Deng D
    Epigenomics; 2020 May; 12(9):801-809. PubMed ID: 32515221
    [No Abstract]   [Full Text] [Related]  

  • 17. m
    Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
    ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
    [No Abstract]   [Full Text] [Related]  

  • 18. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
    He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
    J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Fat Mass- and Obesity-Associated Gene-Dependent Obesogenic Programming by Formula Feeding Compared to Breastfeeding.
    Melnik BC; Weiskirchen R; Stremmel W; John SM; Schmitz G
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.